HERRMANN: Geisel School of Medicine at Dartmouth, Hanover, NH

JAINI: University of Texas Southwestern Medical Center, Dallas, TX

HSU: Oregon Health and Science University, Portland, OR

RUSH: Duke–National University of Singapore (NUS); Duke University School of Medicine, Durham, NC; Texas Tech Health Sciences Center, Odessa, TX

A.J.R. has received consulting fees from Akili Brain Resource Inc., Compass Inc., Curbstone Consultant LLC., Emmes Corp., Holmusk, Janssen (USA); Liva-Nova, Neurocrine, Otsuka-US, Sunovion; speaking fees from Liva-Nova; and royalties from Guilford Press and the University of Texas Southwestern Medical Center, Dallas, TX (for the Inventory of Depressive Symptoms and its derivatives). He is also named co-inventor on 2 patents: US Patent No. 7,795,033: Methods to Predict the Outcome of Treatment with Antidepressant Medication, Inventors: McMahon F.J., Laje G., Manji H., Rush A.J., Paddock S., Wilson A.S.; and US Patent No. 7,906,283: Methods to Identify Patients at Risk of Developing Adverse Events During Treatment with Antidepressant Medication, Inventors: McMahon F.J., Laje G., Manji H., Rush A.J., Paddock S. The remaining authors declare no conflicts of interest.

Please send correspondence to: Zachary Herrmann, DO, New Hampshire Hospital, 36 Clinton Street, Concord, NH 03301 (e-mail: [email protected]).